ROSC - ETF AI Analysis

Top Page

Hartford Multifactor Small Cap ETF (ROSC)

Rating:68Neutral

Price Target:―

The Hartford Multifactor Small Cap ETF (ROSC) has a solid overall rating, driven by strong contributions from holdings like Argan (AGX) and Dillard's (DDS), which benefit from robust financial performance, positive earnings sentiment, and attractive valuations. However, weaker holdings such as Macy's (M) and Supernus Pharmaceuticals (SUPN) face financial challenges and operational inefficiencies, which may have slightly held back the fund's rating. A key risk factor is the ETF's exposure to small-cap stocks, which can be more volatile and sensitive to market fluctuations compared to larger companies.

Positive Factors

Strong Top Holdings

Several of the ETF's top holdings, such as Argan and REV Group, have delivered strong year-to-date performance, supporting overall returns.

Low Expense Ratio

The ETF has a relatively low expense ratio, making it cost-effective compared to many other funds.

Sector Diversification

The ETF is spread across multiple sectors, including Health Care, Financials, and Consumer Cyclical, which helps mitigate risks from sector-specific downturns.

Negative Factors

High Geographic Concentration

The ETF is heavily concentrated in U.S. companies, offering little exposure to international markets and limiting diversification.

Recent Short-Term Underperformance

The ETF has experienced negative one-month performance, which may concern investors looking for consistent short-term gains.

Small Cap Volatility

As a small-cap fund, the ETF may be more sensitive to market fluctuations and economic uncertainty compared to large-cap funds.

ROSC vs. SPDR S&P 500 ETF (SPY)

AUM35.31M

RegionNorth America

Expense Ratio0.34%

Beta0.85

IssuerHartford

Inception DateMar 24, 2015

Dividend Yield2.04%

Asset ClassEquity

Index TrackedHartford Multifactor Small Cap Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume356

30 Day Avg. Volume2,622

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

52.65

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering309

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ROSC Summary

The Hartford Multifactor Small Cap ETF (ROSC) is an investment fund that focuses on small-cap companies, which are smaller businesses with growth potential. It follows the Hartford Multifactor Small Cap Index and includes companies like Macy's and PTC Therapeutics. This ETF uses a strategy to select stocks based on factors like value and quality, aiming to balance growth and stability. Investors might consider ROSC for diversification and the chance to benefit from the dynamic nature of small-cap stocks. However, it’s important to know that small-cap stocks can be more volatile, meaning their prices may go up and down more dramatically than larger companies.

How much will it cost me?The Hartford Multifactor Small Cap ETF (ROSC) has an expense ratio of 0.34%, which means you’ll pay $3.40 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed multifactor strategy to select stocks, aiming to enhance returns and reduce risk. It’s a good option if you’re looking for a strategic approach to small-cap investing.

What would affect this ETF?The Hartford Multifactor Small Cap ETF (ROSC) could benefit from economic growth and innovation in sectors like Health Care and Technology, which are significant parts of its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which can disproportionately impact small-cap companies and consumer-focused sectors like Consumer Cyclical. Additionally, changes in U.S. regulations or trade policies could affect the ETF's performance due to its focus on U.S. small-cap stocks.

ROSC Top 10 Holdings

The Hartford Multifactor Small Cap ETF (ROSC) is leaning heavily into healthcare and financials, which together make up over a third of the fund’s sector exposure. PTC Therapeutics and Indivior are rising stars, delivering strong momentum and earnings guidance that have buoyed performance. On the flip side, Supernus Pharmaceuticals and Buckle are lagging, with mixed technical signals and operational challenges holding them back. While the fund’s focus on U.S. small-cap stocks adds a layer of geographic concentration, its sector diversification helps balance the ups and downs of individual names.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
M	Macy's	1.51%	$531.31K	$5.99B	35.68%	74 Outperform
PTCT	PTC Therapeutics	1.40%	$494.49K	$6.25B	60.85%	73 Outperform
DDS	Dillard's	1.24%	$437.00K	$10.63B	54.19%	76 Outperform
INDV	Indivior	1.17%	$412.87K	$4.32B	207.56%	66 Neutral
AMKR	Amkor	1.12%	$396.51K	$10.67B	66.01%	69 Neutral
AGX	Argan	1.11%	$392.52K	$4.92B	139.48%	76 Outperform
GTX	Garrett Motion	1.09%	$384.34K	$3.26B	82.26%	71 Outperform
NHC	National Healthcare	1.00%	$353.56K	$2.12B	9.21%	72 Outperform
BKE	Buckle	0.98%	$344.80K	$2.89B	7.40%	76 Outperform
HRMY	Harmony Biosciences Holdings	0.97%	$340.92K	$2.20B	14.21%	81 Outperform

ROSC Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

45.19

Positive

100DMA

44.54

Positive

200DMA

42.34

Positive

Market Momentum

MACD

0.49

Negative

RSI

64.61

Neutral

STOCH

92.48

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ROSC, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.58, equal to the 50-day MA of 45.19, and equal to the 200-day MA of 42.34, indicating a bullish trend. The MACD of 0.49 indicates Negative momentum. The RSI at 64.61 is Neutral, neither overbought nor oversold. The STOCH value of 92.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ROSC.

ROSC Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ROSC	―	―	$35.31M	0.34%	―
ITWO	―	―	$86.86M	0.55%	―
FLQS	―	―	$68.74M	0.35%	―
STXK	―	―	$65.26M	0.18%	―
FSCC	―	―	$64.14M	0.36%	―
BKSE	―	―	$60.37M	0.04%	―

Performance Comparison

ROSC

Hartford Multifactor Small Cap ETF

46.95

0.98

2.13%

ITWO

ProShares Russell 2000 High Income ETF

―

FLQS

Franklin LibertyQ U.S. Small Cap Equity ETF

―

STXK

Strive 2000 ETF

―

FSCC

Federated Hermes MDT Small Cap Core ETF

―

BKSE

BNY Mellon US Small Cap Core Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents